Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Insurance Reproductive topic
No spam. Unsubscribe anytime.
Committee backs expanding assisted-reproduction coverage for public employees
Summary
A committee unanimously advanced Senate Bill 242 to expand public employee health benefits to include full coverage for certain assisted reproductive technologies, after personal testimony and a sponsor fiscal estimate.
Get email alerts on the Health Insurance Reproductive topic
No spam. Unsubscribe anytime.
A Senate committee voted unanimously to favorably recommend Senate Bill 242, which would expand Public Employees Health Program (PEHP) coverage to include full coverage for qualified assisted reproductive technology cycles, including in vitro fertilization.
Sponsor Senator Musselman introduced the bill and asked Kate Turner, a Weber State University employee who testified, to explain personal and workforce retention rationales. Turner said she and her husband have been trying to start a family and that IVF costs — she cited a range of $15,000 to $20,000 per cycle — created pressure to look for private-sector jobs that offer fertility benefits. "Providing coverage for qualified assisted reproductive technology cycles would allow many couples who struggle with infertility ... to start and grow their families without adding financial burdens," Turner said.
Musselman said the bill would convert partial coverage in the existing PEHP program into full coverage for IVF and related services. He told senators the office produced a draft fiscal estimate of about $280,000 total and was scheduled to present it to the Executive Appropriations Committee; staff said the fiscal note was still being finalized.
Senators asked about costs and funding sources; the sponsor said actuarial work is underway and that the bill will be discussed further in budget and executive appropriations hearings. The committee voted unanimously to advance the bill.
The sponsor and supporters framed the change as both a worker-retention benefit and a public-health concern amid long-term fertility trends; Musselman cited demographic research about declining fertility rates as additional context for supporting broader access to assisted reproduction.
